# Video Based Directly Observed Therapy for Latent TB

> **NCT03783728** · — · WITHDRAWN · sponsor: **St. Louis University**

## Conditions studied

- Latent Tuberculosis

## Interventions

- **DRUG:** Rifapentine 600 mg orally
- **DRUG:** Isoniazid 900 mg orally
- **DRUG:** Pyridoxine 50 mg orally

## Key facts

- **NCT ID:** NCT03783728
- **Lead sponsor:** St. Louis University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-06-30
- **Primary completion:** 2020-01-31
- **Final completion:** 2020-01-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Investigator is leaving the University
- **Last updated:** 2019-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03783728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03783728, "Video Based Directly Observed Therapy for Latent TB". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03783728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*